Though initially approved by the U.S. Food and Drug Administration (FDA) for use among osteoporosis patients, zoledronic acid may double as a life-extending therapy for older women with breast cancer.
The concept of osteoporosis as a preventable, human-centric disease is a relatively new notion with a long formative history, one that a pair of Norwegian recently spelled out in an issue of the journal Science, Technology and Human Values.
Going through menopause is thought to increase a woman's risk of developing type 2 diabetes, particularly if she has one or more risk factors for the condition. But to what degree does the hormonal change actually affect diabetes risk?
Recent scientific inquiry conducted at Phoenix's Kronos Longevity Research Institute has indicated that the severity of a postmenopausal woman's facial wrinkles may predict her risk of osteoporosis.
Though a number of studies have associated hip and vertebral pressure fractures with an increased likelihood of osteoporosis, a new study from a team of Canadian researchers indicated that broken ankles do not confer a greater risk of subsequent osteoporotic fractures among women age 50 or older.
A study conducted by a group of Japanese bone researchers has found that the osteoporosis drug bazedoxifene, which is still in development, stimulates bone turnover but does not decrease fracture risk in postmenopausal women.
Hormone therapy for osteoporosis can entail some serious side effects, but scientists in Sweden have announced the development of an estrogen-based technique that specifically targets bone tissue.
A growing body of research suggests that consuming polyphenols, like those found in green tea, may help postmenopausal women preserve bone density and slow the onset of osteoporosis.
Researchers in Sweden and the UK have released a report that predicts a general increase of osteoporosis-related injuries over the next decade among aging women.
Researchers in the Czech Republic recently tested the effect of timed osteoporosis medication injections on the daily rhythm of bone turnover among postmenopausal women.
Besides aging and calcium deficiency, what causes osteoporosis? A pair of physicians associated with the Institut National de la Sante et de la Recherche Medicale Unite in Paris recently laid out the known intrinsic and external causes of osteoporosis.
A daily dose of safflower cooking oil may help postmenopausal women who suffer from type 2 diabetes improve many of the symptoms of their condition, according to a new study from Ohio State University researchers.
A team of dental researchers has determined that the use of a class of anti-osteoporosis drugs appears to reduce periodontal disease but not plaque in postmenopausal women.
An international team of researchers has announced that arzoxifene is more effective than raloxifene in treating osteoporosis among postmenopausal women.
A government task force organized by the U.S. Department of Health and Human Services has released new guidelines concerning the age at which Americans should begin getting regularly screened for osteoporosis.